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Abstract 
Human dental pulp cells (hDPCs) exSUHVVRHVWURJHQUHFHSWRU(5LVRIRUPV(5Į(5ȕ and 
(5ȕ, as well as a 7-transmembrane G protein-coupled receptor, GPR30, that mediates 
rapid oestrogen signalling)ROORZLQJRVWHRJHQLFGLIIHUHQWLDWLRQRIWKHVHFHOOV(5ȕDQG
(5ȕwere up regulated approximately 50-fold while (5ĮDQG*35were down regulated, 
but to a much lesser degree (approximately 2-IROG(5ȕwas characterised as a 59 kDa 
protein following SDS-3$*((5ȕZDVGHWHFWHGLQERWKQXFOHDUDQGF\WRSODVPLFFHOO
compartments following immunofluorescence of cultured cells. Furthermore isoform specific 
antibodies detected ERWK(5ȕDQG(5ȕLQ'3&FXOWXUHVDQGin situ analysis of (5ȕ
expression in decalcified tooth/pulp sections identified the odontoblast layer of pulp cells 
juxtaposed to WKHWRRWKHQDPHODVVWURQJO\UHDFWLYHIRUERWK(5ȕLVRIRUPV)LQDOO\WKHXVHRI
isoform specific agonists identified (5ȕDVWKHPDLQreceptor responsible for the pro-
osteogenic effect of oestrogenic hormones in this tissue. 
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Introduction 
Tooth loss (edentulism) is associated with reduction of alveolar bone mass in post-
menopausal women [1-3] and can be counteracted by oestrogen replacement therapy [4-7]. 
Similarly alterations in local and systemic oestrogen concentrations as seen during use of 
chemical contraception or in patients undergoing adjuvant therapeutic strategies in hormone 
dependant breast cancer is associated with challenges to periodontal health [8-10]. Despite 
these important epidemiological findings very little is known about the mechanism of action 
of oestradiol (E2) within the cells and tissues of the oral cavity. In most cells E2 binds to 
cytosolic oestrogen receptors (ERs) which translocate to the nucleus and regulate gene 
expression in association with other trans and cis acting factors. In addition a cell membrane 
associated 7TM G protein linked ER (GPR30) is associated with the acute E2 action in many 
cells.[11, 12]
 
  Several tissues within the oral cavity contain populations of mesenchymal 
stem cells (MSCs) [13-16] which are able to differentiate into a matrix mineralising 
phenotype and this can be stimulated by the action of E2 [17, 18]. Accordingly, ER mRNA 
and protein is expressed in niche MSC populations in the oral cavity including those from 
periodontal ligament- PDLCs- [19, 20] and dental pulp- DPCs [21, 22] although the proteins 
remain rather poorly characterised in these tissues.   Two classical ER isoforms have been 
described- (5ĮDQG(5ȕ- which are structurally and functionally related but which represent 
two different gene products [23, 24]. Although PDLCs and DPCs are reported to express 
both ER isoforms, the literature is conflicted with regard to which ER isoform(s) are involved 
in the differentiation of cells to a matrix mineralising phenotype [25-28] and there is little 
information on the contribution of ER isoforms to the differentiation of stem cell populations 
from other tissue niches within the oral cavity. For these reasons we have characterised ER 
isoform expression and function in DPCs isolated from healthy third molars at the cellular 
and whole tissue level using qRT-PCR, Western blotting, IHC and IF. In addition we have 
used isoform specific agonists to determine the activity RI(5ĮDQG(5ȕGXULQJ 
differentiation of these cells to a matrix mineralisation phenotype.  
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Materials 
PKHQROUHGIUHHĮ-MEM, dextran charcoal stripped serum (DCS) and phosphate buffered 
saline (PBS) was from Lonza (Slough, UK); penicillin/streptomycin (PS), L-glutamine, L-
ascorbic acid and dexamethasone, were from Sigma (Dorset, UK). Collagenase (Type I), 
was from Life Technologies (UK). Tissue culture plastic was from Corning (Amsterdam, 
Netherlands). 4,4',4''-(4-Propyl-[1H]-pyrazole-1,3,5-triyl) trisphenol (PPT) and 2,3-bis(4-
Hydroxyphenyl)-propionitrile (DPN) were from Tocris Bioscience (Abingdon,UK). Details of 
anti-(5ȕDQWLERGLHV are provided in Supplementary Table 1. HRP conjugated secondary 
antibodies anti-mouse (ab97046), anti-rabbit (ab6721) and anti-ȕDFWLQDEZHUH from 
Abcam .For IF, Texas Red ± goat anti-mouse IgG (T6390), Alexa Fluor 594 goat anti-rabbit 
IgG (A11037) and Alexa Fluor 488 donkey anti-mouse IgG(A21202) were from Life 
Technologies, UK.  NP40 cell lysis buffer (FNN0021) was from Invitrogen UK. BCA protein 
assay reagent, WB stripping buffer (46430) and TaqMan primers and probes for qRT-PCR 
were from ThermoScientific, UK. Reagents for WB including 4-15% gradient gels, PVDF 
membranes and molecular weight markers were from BioRad, UK. Tissue culture treated 
glass slides for IF were from Falcon, UK.  All other reagents were of analytical grade or 
better. 
Methods 
Tissue culture 
Isolation, growth and differentiation of DPCs were essentially as described previously [29] 
ZLWKWKHH[FHSWLRQWKDWFHOOVZHUHPDLQWDLQHGDQGSDVVDJHGLQ3KHQRO5HGIUHHĮ0(0
containing, 10% dextran charcoal-stripped serum (PR-DCS). Similarly all experiments (qRT-
PCR, WB, IF, IHC and in vitro bioassay) were done in cells grown in this medium. Unless 
otherwise stated experiments were performed on DPCs derived from healthy pulps from 
three separate donors and triplicate technical replicates were performed in each instance. 
qRT-PCR 
Details of mRNA purification, cDNA synthesis, and qRT-PCR and data analysis have also 
been described previously [29, 30]. Routinely osteogenic markers ALP, OCN, Runx2 and 
RHVWURJHQUHFHSWRULVRIRUPV(5Į(5ȕ(5ȕDQG*35ZHUHDVVD\HGXVLQJ7DT0DQ
probes and primers. GAPDH or HGPRT were used as house- keeping genes. Assay 
identifiers for TaqMan qRT-PCR reactions are presented in Supplementary Table 2.  
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Western blot 
DPCs were cultured for 7, 14 or 21 day under basal or osteogenic conditions and cell lysates 
were prepared using NP40 cell lysis buffer. Protein was quantified using 3LHUFH %&$
protein assay and lysates were stored at -20 ºC prior to analysis. Lysates containing 
equivalent amounts of protein (typically 30-50 ug) were diluted in x4 Laemmli sample buffer 
FRQWDLQLQJȕ-mercaptoethanol (5% final concentration) and electrophoresed through 4-15% 
gradient SDS-PAGE gels for 1h at 120 V. Proteins were transferred to PVDF semi dry 
membranes using the Trans-Blot Turbo (BioRad) for 10 minutes.  Membranes were blocked 
with TBS containing 5% BSA and 0.1% Tween20 (blocking buffer) for at least 1hour on a 
shaker at room temperature. Subsequently, membranes were incubated overnight room 
temperature (RT) with anti-ER-ȕ antibodies Ab 288 and MC10 (1:200; a kind gift from Dr 
John Hawse [31]) in TBS containing 0.1% Tween20 (TBS-T). These antibodies have been 
extensively validated for specificity in WB applications [31, 32] Membranes were washed x5 
with TBS-T and incubated with anti-mouse horseradish peroxidase (HRP) conjugated 
secondary antibody (1:100000) for 2 hours at room temperature in TBS-T. Membranes were 
washed x4 with TBST and x1 with TBS, and developed with ECL substrate. Images were 
processed and stored on the Gel-Doc system (Bio-Rad). For quantitation and densitometry 
blots were stripped with WB stripping buffer and re-probed with anti-ȕDFWLQ 
Immunofluorescence (IF) 
DPCs at passage 4 were seeded in PR-DCS into a 4- chamber polystyrene vessel 
containing tissue culture treated glass slides (Falcon). At 70 % confluence cells were 
washed once with PBS and fixed using ice cold methanol for 10 min. Methanol was 
aspirated and slides left to air dry at RT for 15 min then stored at 4C.  Prior to IF slides were 
rehydrated in PBS for 5 min. Each chamber was blocked using 4 drops of 0.5% skimmed 
milk in PBS (blocking buffer - BB) for 1 hour and 100µl of diluted primary antibody (ab 
78946; 1:50 in BB) was applied for 1 hour followed by 3 x 5 min washes in PBS. A control in 
which primary antibody was omitted was included.  Secondary antibody (Alexa Fluor or 
Texas-Red conjugated) diluted 1:300 in BB was applied for 30 min. After 3x15 min washes 
with PBS slides were mounted using Prolong gold mountant plus DAPI. Slides were allowed 
to cure overnight at RT and covered with tin foil prior to imaging with a Zeiss microscope.  
Immunohistochemistry (IHC) 
Dental pulp tissues were obtained from freshly extracted human third molars as described 
previously [29]. Pulp tissue was gently separated by sterilized tweezers and the tissue then 
preserved in 4% formaldehyde for paraffin embedding and sectioning. Tissues were 
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processed in a VIP Tissue processor (Sakura) through 70 % EtOH, 90 % EtOH, 4 changes 
of 100 % EtOH, 3 changes of 100 % xylene and 3 changes of wax, prior to paraffin 
HPEHGGLQJȝP sections were cut using a Leitz rotary microtome and mounted on glass 
slides using a 40 °C water bath and  slides incubated at 37 °C  overnight prior to staining. 
Slides were de-waxed at 70 °C on hot plates for 30 minutes prior to antigen retrieval. This  
was performed in order to enhance the detection of antigen using Mena Path Revelation 
buffer solution (cat no MP-607-X500) in the Mena Path pressure cooker containing 500 ml 
distilled water for 40 minutes. Slides were then immersed in PBST (1x PBS containing 0.2% 
Tween 20) buffer and all remaining steps performed at room temperature. Slides were 
washed LQ3%67DQGEORFNHGZLWKȝO1RYDFDVWUDSHUR[LGDVH FDW QR5( IRU 
PLQXWHV IROORZHG E\ 3%67 ZDVK  ȝO RI SURWHLQ EORFNLQJ VROXWLRQ (Novacastra - cat no 
RE7102) was added for 15 minutes. Primary anti-(5ȕ antibody (PPG5/10 or 57/3 both 
Serotec) was diluted in Zymed antibody diluent and applied for 1 hour and followed by 3x5 
min washes in PBST. Both antibodies have been extensively validated for use in IHC [31, 
33, 34]. Post primary antibody block (Novolink polymer cat no RE7112) was applied for 30 
min followed by 3x5 min PBS washes. The slides then were incubated in diluted DAB 
chromogen (1:20 v/v) (cat no RE7105) for 5 min. The slides were counterstained in 0D\HU¶V 
Haematoxylin for 1 min and washed under running tap water, then in 6FRWW¶V WDS ZDWHU
substitute for 2 minutes followed by a further wash in running tap water. The slides were 
dehydrated in a series of graded ethanols (25% for 15 seconds, 50% for 2 minutes, 70% for 
5 minutes, and 100% for 5 minutes) and were immersed in xylene 3 times for 3 minutes. The 
slides were mounted in DPX and left overnight to set prior to scanning using the 
6FDQ6FRSH V\VWHP DW [ PDJQLILFDWLon, and then visualiVHG XVLQJ ,PDJH6FRSH
software. For staining of serial sections from demineralised tooth freshly extracted human 
third molars were washed with dH2Oand any attached tissue was removed. Teeth were 
placed in 10% EDTA solution (300 mg of NaOH was added to the solution to enhance the 
dissolving process). The solution was changed every 2-3 days. The decalcification process 
was monitored weekly by x-ray until teeth were completely translucent. Decalcified teeth 
were paraffin embedded and sectioned as described for pulp tissue.  
In vitro bioassay 
ALP activity was assayed as described previously [35]  with some modifications. Briefly 
DPCs were grown to confluence in PF-DCS. ER agonist (DPN or PPT) was added at the 
indicated concentrations in osteogenic differentiation medium. Medium (inclusive of ER 
agonists) was changed at days 4, 7 and 10 and cultures were terminated at day 14. Cells 
were lysed by the addition of 200ul 0.1% Triton X-100 followed by three cycles of freeze-
thawing. Lysates were centrifuged (5 min; 10000g) and 20ul was assayed for ALP activity. 
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Data are presented as nmol p-nitrophenol (pNP) formed per ug DNA and represent mean ± 
SD (n=3). 
Statistics 
Data were analysed by 6WXGHQW¶V XQSDLUHG W-test (densitometry) or by two way Anova 
IROORZHG E\ %RQIHUURQL¶V PXOWLSOH FRPSarisons test (bioassay) (GraphPad Prism v 7.0) In 
both instance differences were considered significant at p< 0.05. 
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Results 
Treatment of DPCs with dexamethasone (Dx) and ascorbic acid (AA) caused osteogenic 
differentiation of DPCs as evidenced by up regulation of early (ALP) and late (OCN) markers 
of osteogenesis. The transcription factor RunX2 important for the process of osteogenic 
differentiation was also up regulated at both early (1wk) and late (3wk) time points (Fig 1). In 
addition differentiated cell cultures stained positively for both ALP and Alizarin Red an 
indicator of matrix mineralisation (data not shown). Therefore under our culture conditions 
differentiation of DPC s was achieved and confirmed recent findings from our laboratories 
[29]. We next investigated the expression of ER isoforms during differentiation of DPCs. As 
ZHOODV(5ĮDQG(5ȕZHDOVRLQYHVWLJDWHGWKHH[SUHVVLRQRIWKHPRUHUHFHQWO\ described 
membrane associated G protein linked ER ± GPR30. We found that there was a consistent 
XSUHJXODWLRQRIERWKLVRIRUPVRI(5ȕ which we examined (-ȕDQG-ȕDWHDFKWLPe point. 
7KHUHIRUH(5ȕZDVXSUHJXODWHGDQGIROGDWGD\V 14 and 21 
UHVSHFWLYHO\LQGLIIHUHQWLDWLQJ'3&VPHDQ6(0Q )RU(5ȕFRUUHVSRQGLQJYDOXHV
were 32±9, 53±15 and 53±8 fold at days 7, 14 and 21 (mean ± SEM; n=3). ± Fig2. For the 
other two isoforms of ER examined there was a tendency for down regulation especially at 
the later time points. 7KHUHIRUHDWGD\VLQFXOWXUH(5ĮDQG*35ZHUHGRZQUHJXODWHG
to 62±15 and 64±0.5% respectively of the levels seen in undifferentiated DPCs. 
%HFDXVH(5ȕ protein has been largely uncharacterised in DPCs we used 2 extensively 
YDOLGDWHG0DEVWRGHWHFW(5ȕLQO\VDWHVSUHSDUHGIURPXQGLIIHUHQWLDWHG (B) and differentiated 
(O) cell cultures - see Methods section. WBs indicated a protein of Mr 59kDa which is close 
WRWKHWKHRUHWLFDO0UIRU(5ȕN'D- Fig3 .A non-specific cross reacting species was 
also apparent at Mr ~ 65 kDa. This KDVSUHYLRXVO\EHHQGHVFULEHGLQWKH(5ȕLQGXFLEOHFHOO
line used to validate Ab288 [32].  Of note however densitometric analysis (Fig 3b) indicated 
that (5ȕlevels in lysates from osteogenically differentiated cells did not differ from lysates 
prepared from undifferentiated cells (p=0.46). As such this data is not consistent with qRT-
PCR data reported in Fig2 LQGLFDWLQJLQFUHDVHG(5ȕDQGȕP51$LQGLIIHUHQWLDWHGFHOOV 
(see Discussion section). 7KHSUHVHQFHRI(5ȕSURWHLQZDVFRQILUPHGE\,) using clearly 
showing the presence of the protein in the cytosol and nucleus of DPCs (Fig4). In addition 
WKHSUHVHQFHRIERWKȕDQGȕLVRIorms was confirmed by IHC using validated and non-
FURVVUHDFWLYH(5ȕLVRIRUPVSHFLILFDQWLERGLHV (Fig 5) and ERWK(5ȕLVRIRUPVZHUHGHWHFWHG
in whole pulps obtained after sectioning decalcified third molars (Fig 6). Interestingly in these 
whole tooth sections VWDLQLQJIRU(5ȕZDVSDUWLFXODUO\HYLGHQWLQWKHSHULSKHUDOSXOSVXE-
enamel) layer of tissue which contains mature and precursor odontoblast cells. 
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 Finally we investigated a possible functional role for ER during differentiation of DPCs using 
alkaline phosphatase (ALP) activity as a marker of osteogenic differentiation as described 
previously in our laboratories [29]. PPT LVDVHOHFWLYHDJRQLVWRI(5Į(410-IROGYȕ) whereas 
DPN is DQ(5ȕVHOHFWLYHDJRQLVW (70-fold v Į [36, 37]. Fig 7 shows that DPN stimulates ALP 
activity in a dose dependent fashion over the concentration range 10-8 ± 10-5M whilst PPT 
had little effect on ALP activity. These data suggest that the osteogenic promoting activity of 
E2 in '3&VLVPHGLDWHGE\WKH(5ȕisoform. 
Discussion 
Our observation of ER expression in DPCs confirms previous reports of expression in these 
cells [21, 22]. Although we report for the first time up regulation of both (5ȕDQG(5ȕ in 
DPCs during osteogenic differentiation, LQFUHDVHGH[SUHVVLRQRI(5ȕGXULQJRVWHRJHQLF
differentiation of closely related periodontal ligament stem cells  (PDLCs) has been 
described previously [38]. :HFKDUDFWHULVHG(5ȕSURWHLQLQ'3&O\VDWHVE\:%DQGLQFHOOV
and whole pulp sections by IF and IHC with a panel of validated antibodies directed towards 
different epitopes RI(5ȕ (Supplementary Table 1). In WB we found a main reactive band 
ZLWKD0UIRUWKH(5ȕVSHFLHVLQ'3&RIN'D)LJXUH,QDGGLWLRQDKLJKHU0UVSHFLHV
was identified in WB studies (approx.66kDa). Higher Mr non-specific reactivity with both 
Ab288 and MC10 has been described although specific reactivity was confirmed at 59kDa 
using doxycycline LQGXFLEOH(5ȕLQWKH0'$-MB-231 breast cancer cell line [32] . The 
epitopes recognised by each of the antibodies used in WB lie within the N-terminal portion of 
(5ȕSURWHLQDQGDVVXFKZRXOGEHH[SHFWHGWRUHFRJQLVHERWK(5ȕDQG(5ȕLVRIRUPV
+RZHYHUZHIRXQGQRHYLGHQFHRI(5ȕVSHFLHV0UN'D'HVSLWHWKHIDFWWKDWPDQ\
VWXGLHVKDYHH[DPLQHG(5ȕLVRIRUPVH[SUHVVLRQE\:%in different tissues [38-42] in most 
instances these antibodies have not been validated for specific isoform detection using this 
technique and this area requires further investigation. Although previous studies have 
assumed that current commercially available pan-(5ȕDQWLERGLHVGHWHFWPDLQO\WKH(5ȕ
isoform in WB of cell lysates we note that in our experimeQWVȕDQGȕVSHFLILFDQWLVHUD
were unreactive with DPC lysate despite previous reports of specific reactivity of these 
reagents in human  Leydig cells [43], colorectal carcinoma cells [44] and breast tumour 
tissue [45]. Although there may several reasons for this (sensitivity, specificity, and epitope 
availability) we note that WKHODFNRIUHDFWLYLW\RIWKH(5ȕVSHFLILFDQWLERG\RQ:%FRQILUPV
the findings of an extensive validation study reported recently by Nelson et al [32]. In 
contrast ERWK(5ȕDQG(5ȕVSHFLHVZHUHGHWHFWHGE\,+&)LJ, a methodology for 
which the antibodies used have been extensively validated (see above) and this confirms 
our qRT-PCR data.  
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There are some functional studies describing E2 action in cells and tissues within the oral 
cavity [25, 26, 46-48]. PDLCs isolated from ovariectomized (OVX) rats showed decreased 
matrix mineralisation compared to cells derived from sham operated controls and E2 
treatment of OVX derived cell cultures enhanced the osteogenic differentiation of these 
cultures [28].  Subsequent siRNA transfection RI3'/&VVXJJHVWHGDUROHIRUERWK(5ĮDQG
(5ȕLVRIRUPVLQ(2 mediated action [27, 28].However, in direct contrast two studies have 
XVHGVL51$WUDQVIHFWLRQWRVKRZWKDW(5ȕis the main ER isoform involved in E2 stimulated 
osteogenic differentiation of PDLCs [25, 26]. Although these latter studies are consistent with 
our findingVRI(5ȕDFWLYLW\LQ'3&VXVLQJLVRIRUPVSHFLILFDJRQLVWV)LJWKLVDUHDUHTXLUHV
further investigation. There is also conflicting data concerning the signalling pathways used 
by E2 during stimulation of osteogenic differentiation of DPCs with reports that activation [18] 
or inhibition [17] of NF-ț%LVUHTXLUHGIRUGLIIHUentiation of DPCs to a matrix mineralising 
phenotype. In stem cells from apical papillae (SCAP) E2 is reported to stimulate 
osteogenesis via activation of the MAPK pathway [49] although whether this pathway is 
activated in DPCs is currently unknown. Although there are no other reports on GPR30 
expression in dental tissues recent studies using membrane impermeable E2 conjugates 
and phytoestrogens suggest that this cell membrane ER can be activated in DPCs and 
PDLCs [46, 50] and this is an area worthy of further study. 
 We report dissociation between ERȕP51$DQGSURWHLQH[SUHVVLRQ (5ȕDQGȕP51$LV
up regulated several fold during osteogenic differentiation of DPCs but such changes are not 
translated into differences in protein levels (Figs 2 and 3). A disconnection EHWZHHQ(5ȕ
mRNA and protein levels has been reported by other workers [51, 52], with work on breast 
cancer suggesting this may be as a result of translational control [53, 54].This is also an area 
worthy of further investigation. Finally differentiation of DPCs in our laboratories is achieved 
with dexamethasone and ascorbic acid and it is important to confirm that changes in (5ȕ
expression are due to differentiation per se and not to the independent action of either 
agent. Although a previous report suggested that  GH[DPHWKDVRQHKDGQRHIIHFWRQ(5ȕ
mRNA expression in discrete rat CNS nuclei [51] LWZLOOEHLPSRUWDQWWRHVWDEOLVKWKDW(5ȕLV
up regulated under dexamethasone free differentiating conditions. The osteogenic 
differentiation of stem cells derived from subcutaneous adipose tissue (ASCs) and bone 
marrow (BM-MSCs) in the absence of dexamethasone has been described previously [55] 
and such experiments on DPCs are currently underway in our laboratories.  
Acknowledgements 
AA and HA acknowledges the Royal Embassy of Saudi Arabia ± Cultural Bureau (UK) for 
financial support. RE acknowledges WELMEC, a Centre of Excellence in Medical 
10 
 
Engineering funded by the Wellcome Trust and EPSRC, under grant number WT 
088908/Z/09/Z for financial support. We thank Dr John Hawse (Department of Biochemistry and 
Molecular Biology, Mayo Clinic, Rochester, Minnesota) for kindly providing monoclonal anti-(5ȕ
MC10. 
References 
1. Daniell, H.W., Postmenopausal tooth loss. Contributions to edentulism by osteoporosis and 
cigarette smoking. Arch Intern Med, 1983. 143(9): p. 1678-82. 
2. Krook, L., et al., Experimental studies on osteoporosis. Methods Achiev Exp Pathol, 1975. 7: 
p. 72-108. 
3. Rowe, D.J., Bone loss in the elderly. J Prosthet Dent, 1983. 50(5): p. 607-10. 
4. Grodstein, F., G.A. Colditz, and M.J. Stampfer, Post-menopausal hormone use and tooth loss: 
a prospective study. J Am Dent Assoc, 1996. 127(3): p. 370-7, quiz 392. 
5. Grodstein, F., G.A. Colditz, and M.J. Stampfer, Tooth loss and hormone use in 
postmenopausal women. Compend Contin Educ Dent Suppl, 1998(22): p. S9-16. 
6. Norderyd, O.M., et al., Periodontal status of women taking postmenopausal estrogen 
supplementation. J Periodontol, 1993. 64(10): p. 957-62. 
7. Paganini-Hill, A., The benefits of estrogen replacement therapy on oral health. The Leisure 
World cohort. Arch Intern Med, 1995. 155(21): p. 2325-9. 
8. Taichman, L.S., et al., Periodontal Health in Women With Early-Stage Postmenopausal Breast 
Cancer Newly on Aromatase Inhibitors: A Pilot Study. J Periodontol, 2015. 86(7): p. 906-16. 
9. Dzeletovic, B., et al., Dental pulp blood flow and its oscillations in women with different 
estrogen status. J Endod, 2012. 38(9): p. 1187-91. 
10. Karthik, S.J., et al., Evaluation of estrogen receptor and circulating estradiol levels in pre- and 
postmenopausal women with periodontal disease. J Int Acad Periodontol, 2009. 11(3): p. 
202-5. 
11. Carmeci, C., et al., Identification of a gene (GPR30) with homology to the G-protein-coupled 
receptor superfamily associated with estrogen receptor expression in breast cancer. 
Genomics, 1997. 45(3): p. 607-17. 
12. Prossnitz, E.R., et al., Estrogen signaling through the transmembrane G protein-coupled 
receptor GPR30. Annu Rev Physiol, 2008. 70: p. 165-90. 
13. Gronthos, S., et al., Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc 
Natl Acad Sci U S A, 2000. 97(25): p. 13625-30. 
14. Morsczeck, C., et al., Isolation of precursor cells (PCs) from human dental follicle of wisdom 
teeth. Matrix Biology, 2005. 24(2): p. 155-165. 
15. Seo, B.-M., et al., Investigation of multipotent postnatal stem cells from human periodontal 
ligament. The Lancet, 2004. 364(9429): p. 149-155. 
16. Sonoyama, W., et al., Characterization of the apical papilla and its residing stem cells from 
human immature permanent teeth: a pilot study. Journal of endodontics, 2008. 34(2): p. 
166-171. 
17. Wang, Y., et al., Estrogen deficiency inhibits the odonto/osteogenic differentiation of dental 
pulp stem cells via activation of the NF-kappaB pathway. Cell Tissue Res, 2013. 352(3): p. 
551-9. 
18. Wang, Y., et al., 10(-7) m 17beta-oestradiol enhances odonto/osteogenic potency of human 
dental pulp stem cells by activation of the NF-kappaB pathway. Cell Prolif, 2013. 46(6): p. 
677-84. 
19. Jonsson, D., et al., Immunocytochemical demonstration of estrogen receptor beta in human 
periodontal ligament cells. Arch Oral Biol, 2004. 49(1): p. 85-8. 
11 
 
20. Morishita, M., A. Shimazu, and Y. Iwamoto, Analysis of oestrogen receptor mRNA by reverse 
transcriptase-polymerase chain reaction in human periodontal ligament cells. Arch Oral Biol, 
1999. 44(9): p. 781-3. 
21. Inaba, T., et al., Expression status of mRNA for sex hormone receptors in human dental pulp 
cells and the response to sex hormones in the cells. Arch Oral Biol, 2013. 58(8): p. 943-50. 
22. Jukic, S., et al., Estrogen receptors in human pulp tissue. Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod, 2003. 95(3): p. 340-4. 
23. Jia, M., K. Dahlman-Wright, and J.A. Gustafsson, Estrogen receptor alpha and beta in health 
and disease. Best Pract Res Clin Endocrinol Metab, 2015. 29(4): p. 557-68. 
24. Warner, M., S. Nilsson, and J.A. Gustafsson, The estrogen receptor family. Curr Opin Obstet 
Gynecol, 1999. 11(3): p. 249-54. 
25. Liang, L., et al., Effect of estrogen receptor beta on the osteoblastic differentiation function of 
human periodontal ligament cells. Arch Oral Biol, 2008. 53(6): p. 553-7. 
26. Mamalis, A., et al., Oestrogen regulates proliferation, osteoblastic differentiation, collagen 
synthesis and periostin gene expression in human periodontal ligament cells through 
oestrogen receptor beta. Arch Oral Biol, 2011. 56(5): p. 446-55. 
27. Pan, F., et al., Oestrogen receptors are involved in the osteogenic differentiation of 
periodontal ligament stem cells. Biosci Rep, 2011. 31(2): p. 117-24. 
28. Zhang, B., et al., Estrogen deficiency leads to impaired osteogenic differentiation of 
periodontal ligament stem cells in rats. Tohoku J Exp Med, 2011. 223(3): p. 177-86. 
29. Alkharobi, H., et al., IGFBP-2 and -3 co-ordinately regulate IGF1 induced matrix 
mineralisation of differentiating human dental pulp cells. Stem Cell Res, 2016. 17(3): p. 517-
522. 
30. El-Gendy, R., et al., Osteogenic differentiation of human dental pulp stromal cells on 45S5 
Bioglass(R) based scaffolds in vitro and in vivo. Tissue Eng Part A, 2013. 19(5-6): p. 707-15. 
31. Wu, X., et al., Development, characterization, and applications of a novel estrogen receptor 
beta monoclonal antibody. J Cell Biochem, 2012. 113(2): p. 711-23. 
32. Nelson, A.W., et al., Comprehensive assessment of estrogen receptor beta antibodies in 
cancer cell line models and tissue reveals critical limitations in reagent specificity. Mol Cell 
Endocrinol, 2017. 440: p. 138-150. 
33. Critchley, H.O., et al., Wild-type estrogen receptor (ERbeta1) and the splice variant 
(ERbetacx/beta2) are both expressed within the human endometrium throughout the normal 
menstrual cycle. J Clin Endocrinol Metab, 2002. 87(11): p. 5265-73. 
34. Saunders, P.T., et al., ERbeta1 and the ERbeta2 splice variant (ERbetacx/beta2) are expressed 
in distinct cell populations in the adult human testis. J Clin Endocrinol Metab, 2002. 87(6): p. 
2706-15. 
35. Kim, J.G., et al., Stimulating effects of quercetin and phenamil on differentiation of human 
dental pulp cells. Eur J Oral Sci, 2013. 121(6): p. 559-65. 
36. Meyers, M.J., et al., Estrogen receptor-beta potency-selective ligands: structure-activity 
relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med 
Chem, 2001. 44(24): p. 4230-51. 
37. Stauffer, S.R., et al., Pyrazole ligands: structure-affinity/activity relationships and estrogen 
receptor-alpha-selective agonists. J Med Chem, 2000. 43(26): p. 4934-47. 
38. Tang, X., et al., Up-regulation of estrogen receptor-beta expression during osteogenic 
differentiation of human periodontal ligament cells. J Periodontal Res, 2008. 43(3): p. 311-
21. 
39. Crider, A., et al., Dysregulation of estrogen receptor beta (ERbeta), aromatase (CYP19A1), 
and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjects. Mol 
Autism, 2014. 5(1): p. 46. 
40. Hamilton-Burke, W., et al., Phosphorylation of estrogen receptor beta at serine 105 is 
associated with good prognosis in breast cancer. Am J Pathol, 2010. 177(3): p. 1079-86. 
12 
 
41. Shatalova, E.G., et al., Estrogen and cytochrome P450 1B1 contribute to both early- and late-
stage head and neck carcinogenesis. Cancer Prev Res (Phila), 2011. 4(1): p. 107-15. 
42. Tam, A., et al., Estradiol increases mucus synthesis in bronchial epithelial cells. PLoS One, 
2014. 9(6): p. e100633. 
43. Carpino, A., et al., Detection of aromatase and estrogen receptors (ERalpha, ERbeta1, 
ERbeta2) in human Leydig cell tumor. Eur J Endocrinol, 2007. 157(2): p. 239-44. 
44. Wong, N.A., et al., ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro 
study of clinicopathological and molecular correlates. J Pathol, 2005. 207(1): p. 53-60. 
45. Shaaban, A.M., et al., Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 
identifies distinct prognostic outcome for breast cancer patients. Clin Cancer Res, 2008. 
14(16): p. 5228-35. 
46. Manokawinchoke, J., et al., Estradiol induces osteoprotegerin expression by human dental 
pulp cells. Odontology, 2016. 104(1): p. 10-8. 
47. Morishita, M., et al., The effects of oestrogen on osteocalcin production by human 
periodontal ligament cells. Arch Oral Biol, 1998. 43(4): p. 329-33. 
48. Morishita, M., et al., Estradiol enhances the production of mineralized nodules by human 
periodontal ligament cells. J Clin Periodontol, 1999. 26(11): p. 748-51. 
49. Li, Y., et al., 17beta-estradiol promotes the odonto/osteogenic differentiation of stem cells 
from apical papilla via mitogen-activated protein kinase pathway. Stem Cell Res Ther, 2014. 
5(6): p. 125. 
50. Luo, L.J., et al., Genistein regulates the IL-1 beta induced activation of MAPKs in human 
periodontal ligament cells through G protein-coupled receptor 30. Arch Biochem Biophys, 
2012. 522(1): p. 9-16. 
51. Suzuki, S. and R.J. Handa, Regulation of estrogen receptor-beta expression in the female rat 
hypothalamus: differential effects of dexamethasone and estradiol. Endocrinology, 2004. 
145(8): p. 3658-70. 
52. Vinayagam, R., et al., Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with 
outcome of adjuvant endocrine treatment for primary breast cancer--a retrospective study. 
BMC Cancer, 2007. 7: p. 131. 
53. Smith, L., et al., Differential regulation of oestrogen receptor beta isoforms by 5' 
untranslated regions in cancer. J Cell Mol Med, 2010. 14(8): p. 2172-84. 
54. Smith, L., et al., Expression of oestrogen receptor beta isoforms is regulated by 
transcriptional and post-transcriptional mechanisms. Biochem J, 2010. 429(2): p. 283-90. 
55. Kim, J.H., et al., Hypoxia Suppresses Spontaneous Mineralization and Osteogenic 
Differentiation of Mesenchymal Stem Cells via IGFBP3 Up-Regulation. Int J Mol Sci, 2016. 
17(9). 
 
 
 
 
 
 
 
13 
 
Figure Legends 
 
Fig 1 qRT-PCR analysis of osteogenic marker expression in differentiating DPCs. ALP, OCN 
and Runx2 expression was determined at 7 and 21 day time points and show up regulation 
of early (ALP), late (OCN) and time independent (RunX2) osteogenic markers.  
.Fig 2 qRT-PCR analysis of ER isoform expression in differentiating DPCs. (5Į(5ȕ, 
(5ȕ and GPR30 expression was determined at 7, 14 and 21 day time points in basal and 
differentiated cultures of DPCs(5ȕDQGȕLVRIRUPVZHUHXSUHJXODWHGIROORZLQJ
GLIIHUHQWLDWLRQDQG(5ĮDQG*35ZHUHGRZQUHJXODWHGWRDOHVVHUGHJUHH 
Fig 3 (a) WB of ERȕLQO\VDWHVRIEDVDOB) and osteogenically differentiated (O) DPCs at 7 
and 14 days. Blots were probed with ab 288.  Mr for main reactive species is indicated. 
Similar results were obtained with Mab MC10. This experiment was repeated 3 times for 
each antibody and representative data is shown. (b) Densitometric analyVLVRI(5ȕSURWHLQLQ
basal (b) and osteogenically differentiated (o) DPC lysates. WBs were stripped and re-
SUREHGZLWKȕDFWLQDVORDGLQJFRQWUol. Triplicate tracks from each of 4 separate blots were 
analysed and data are represented as mean ± SD n=10 basal; n=11 osteogenic AU = 
arbitrary units. P=0.46.  
Fig 4 ,)GHWHFWLRQRI(5ȕH[SUHVVLRQLQ'3&V&HOOVZHUHJURZQLQWLVVXHFXOWXUHWUHDWHG
glasVVOLGHVDQGSURFHVVHGIRU,)GHWHFWLRQRI(5ȕ'$3,WRS(5ȕPLGGOHDQGPHUJHG
(bottom) images are shown 
Fig 5 IHC GHWHFWLRQRI(5ȕH[SUHVVLRQLQGHQWDOSXOSWLVVXH3XOSWLVVXHZDVLVRODWHGIURP
healthy third molars and processed for IHC. Pan-(5ȕ(5ȕDQG(5ȕLVRIRUPGHWHFWLRQLV
shown (arrowed) in relevant figure panels. In negative controls primary antibody was 
omitted.  
Fig 6 Demineralised tooth sections were stained with H&E, pDQ(5ȕ(5ȕDQG(5ȕ)RU
H&E panel the location of residual enamel matrix (O) along with dental pulp (P) is indicated. 
6WURQJVWDLQLQJRI(5ȕLQWKHRGRQWREODVWOD\HULVLQGLFDWHGE\DUURZV  
 Fig 7 In vitro bioassay of selective ER agonists. AP activity was used as a marker of 
osteogenic differentiation LQ'3&V(5ĮVHOHFWLYH337DQG(5ȕVHOHFWLYH'31DFWLYLW\
was determined over the concentration range 0-10 uM. Data represent triplicate technical 
replicates and this experiment was repeated 3 times. Data are presented as mean ± SD; 
14 
 
n=3. In some instances symbol size is larger than SD. Analysis was by two-way Anova 
IROORZHGE\%RQIHUURQL¶VPXOWLSOHFRPSDULVRQVWHVWSS 
Supplementary Tables 
7DEOH6'HWDLOVIRU(5ȕantibodies used in the current study. 
Table 2S TaqMan assay identifiers for qRT-PCR Further details are available at 
http://www.appliedbiosystems.com 
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Figure 3a  
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                                  Supplementary Table 1 
 
 
                     Supplier                       Host                            Epitope                Application 
ab 78946      Abcam                 rabbit polyclonal               peptide (S105)             IF 
ab 288          Abcam                 mouse monoclonal          (5ȕ-153                   WB                       
MC10           Wu et al [31]        mouse monoclonal           (5ȕ-140                   WB 
PPG5/10      Thermofisher       mouse monoclonal          C-WHUPLQDOȕ             IHC 
57/3              GeneTex             mouse monoclonal          C-WHUPLQDOȕ             IHC 
 
IF immunofluorescence; WB Western blot; IHC immunohistochemistry 
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                               Supplementary Table 2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene 
name 
 
Taqman ® gene 
expression assay 
number 
GAPDH Hs99999905_m1 
HGPRT Hs03929098_m1 
ALP Hs01029144_m1 
Runx2 Hs00231692_m1 
OCN Hs00609452_g1 
(5Į Hs00174860_m1 
(5ȕ Hs01100359_m1 
(5ȕ Hs01105520_m1 
GPR30 Hs01116133_m1 
